(Q51022142)

English

Better survival with interleukin-2-based regimens? Possibly only in highly selected patients.

scientific article published on 23 February 2004

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14981101

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/14981101

title

Better survival with interleukin-2-based regimens? Possibly only in highly selected patients. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14981101

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/14981101

author name string

Sylvie Négrier

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14981101

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/14981101

language of work or name

English

0 references

publication date

23 February 2004

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14981101

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/14981101

published in

Journal of Clinical Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14981101

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/14981101

volume

22

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14981101

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/14981101

issue

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14981101

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/14981101

page(s)

1174-1176

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14981101

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/14981101

Identifiers

DOI

10.1200/JCO.2004.01.998

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14981101

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/14981101

Fatcat ID

release_svsrvybhvvdklf5wr7ljviyn2q

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/svsrvybhvvdklf5wr7ljviyn2q

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

14981101

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14981101

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/14981101

(Q51022142)

Better survival with interleukin-2-based regimens? Possibly only in highly selected patients.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)